Journal
NANOMEDICINE
Volume 15, Issue 18, Pages 1805-1815Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2020-0110
Keywords
brain tumor; gene delivery; nanoparticles; pediatrics; safety
Funding
- NIH [R01CA228133, P41EB028239]
Ask authors/readers for more resources
Current standard of care for many CNS tumors involves surgical resection followed by chemotherapy and/or radiation. Some pediatric brain tumor types are infiltrative and diffuse in nature, which reduces the role for surgery. Furthermore, children are extremely vulnerable to neurological sequelae from surgery and radiation therapy, thus alternative approaches are in critical need. As molecular targets underlying various cancers become more clearly defined, there is an increasing push for targeted gene therapies. Viral vectors and nonviral nanoparticles have been thoroughly investigated for gene delivery and show promise as vectors for gene therapy for pediatric brain cancer. Here, we review inorganic and organic materials in development for nanoparticle gene delivery to the brain with a particular focus on safety.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available